Type : Propionate, Dimethoxyphenyl, Neuromuscular Nondepolarizing Agents, Nicotinic antagonist, Bisquaternary, Not AlphaBeta Hydrolase target, Isoquinoline
Chemical_Nomenclature : 5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl
Canonical SMILES :
InChI :
InChIKey :
Other name(s) : cisatracurium besylate || 3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate
Families : No family
Protein : No protein
| Title : Neuromuscular Blocking Agents in Anesthesia: A Narrative Review of Contemporary Challenges and Reversal Approaches - Radkowski_2026_J.Clin.Med_15_ |
| Author(s) : Radkowski P , Jutrzenka M , Szewczyk M , Witkowska A , Muza M , Onichimowski D , Grabarczyk L |
| Ref : J Clin Med , 15 : , 2026 |
| Abstract : |
| PubMedSearch : Radkowski_2026_J.Clin.Med_15_ |
| PubMedID: 42123245 |
| Title : Clinical pharmacokinetics of the newer neuromuscular blocking drugs - Atherton_1999_Clin.Pharmacokinet_36_169 |
| Author(s) : Atherton DP , Hunter JM |
| Ref : Clinical Pharmacokinetics , 36 :169 , 1999 |
| Abstract : |
| PubMedSearch : Atherton_1999_Clin.Pharmacokinet_36_169 |
| PubMedID: 10223167 |